Highlighting the Role of Obesity and Insulin Resistance in Type 1 Diabetes and Its Associated Cardiometabolic Complications

Poynton FJ. Five cases of diabetes mellitus in young children. Br Med J. 1923;1(3242):277–9. https://doi.org/10.1136/bmj.1.3242.277.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Eeg-Olofsson K, Cederholm J, Nilsson PM, et al. Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care. 2010. https://doi.org/10.2337/dc10-0398 Published online.

Article  PubMed  PubMed Central  Google Scholar 

Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care. 2003. https://doi.org/10.2337/diacare.26.4.1258 Published online.

Article  PubMed  Google Scholar 

Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2014. https://doi.org/10.1002/14651858.CD009122.pub2 Published online.

Article  PubMed  PubMed Central  Google Scholar 

Kopp W. How western diet and lifestyle drive the pandemic of obesity and civilization diseases. Diabetes Metab Syndr Obes Targets Ther. 2019. https://doi.org/10.2147/DMSO.S216791 Published online.

Article  Google Scholar 

Minges KE, Whittemore R, Weinzimer SA, Irwin ML, Redeker NS, Grey M. Correlates of overweight and obesity in 5529 adolescents with type 1 diabetes: The T1D Exchange Clinic Registry. Diabetes Res Clin Pract. 2017. https://doi.org/10.1016/j.diabres.2017.01.012 Published online.

Article  PubMed  PubMed Central  Google Scholar 

Baskaran C, Volkening LK, Diaz M, Laffel LM. A decade of temporal trends in overweight/obesity in youth with type 1 diabetes after the Diabetes Control and Complications Trial. Pediatr Diabetes. 2015;16(4):263–70. https://doi.org/10.1111/pedi.12166.

CAS  Article  PubMed  Google Scholar 

Livingstone SJ, Levin D, Looker HC, et al. Estimated life expectancy in a scottish cohort with type 1 diabetes, 2008–2010. J Am Med Assoc. 2015. https://doi.org/10.1001/jama.2014.16425 Published online.

Article  Google Scholar 

Huo L, Harding JL, Peeters A, Shaw JE, Magliano DJ. Life expectancy of type 1 diabetic patients during 1997–2010: a national Australian registry-based cohort study. Diabetologia. 2016. https://doi.org/10.1007/s00125-015-3857-4 Published online.

Article  PubMed  Google Scholar 

Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001. https://doi.org/10.1007/PL00002934 Published online.

Article  PubMed  Google Scholar 

Rawshani A, Sattar N, Franzén S, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet. 2018. https://doi.org/10.1016/S0140-6736(18)31506-X Published online.

Article  PubMed  PubMed Central  Google Scholar 

Shamoon H, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993 Published online.

The Diabetes Control, Complications Trial (DCCT) Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial. Am J Cardiol. 1995. https://doi.org/10.1016/S0002-9149(99)80683-3 Published online.

Article  Google Scholar 

Nathan DM, Cleary PA, Backlund JYC, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005. https://doi.org/10.1056/NEJMoa052187 Published online.

Article  PubMed  Google Scholar 

Wadén J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop PH. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes. 2009. https://doi.org/10.2337/db09-0693 Published online.

Article  PubMed  PubMed Central  Google Scholar 

Klein BEK, Klein R, McBride PE, et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med. 2004. https://doi.org/10.1001/archinte.164.17.1917 Published online.

Article  PubMed  Google Scholar 

•• Orchard TJ, Olson JC, Erbey JR, et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh epidemiology of diabetes complications study. Diabetes Care. 2003. https://doi.org/10.2337/diacare.26.5.1374 Published online. This prospective cohort study showed that IR, as measured by the eGDR, was a strong predictor of hard CVD endpoints, such as MI or CAD death in people with T1D during the 10-year follow-up period.

Article  PubMed  Google Scholar 

Miller RG, Costacou T, Orchard TJ. Risk factor modeling for cardiovascular disease in type 1 diabetes in the pittsburgh epidemiology of diabetes complications (EDC) study: a comparison with the diabetes control and complications trial/epidemiology of diabetes interventions and complication. Diabetes. 2019. https://doi.org/10.2337/db18-0515 Published online.

Article  PubMed  PubMed Central  Google Scholar 

Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014. https://doi.org/10.1056/NEJMoa1408214 Published online.

Article  PubMed  Google Scholar 

Finne P, Reunanen A, Stenman S, Groop PH, Grönhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. J Am Med Assoc. 2005. https://doi.org/10.1001/jama.294.14.1782 Published online.

Article  Google Scholar 

Hero C, Svensson AM, Gidlund P, Gudbjörnsdottir S, Eliasson B, Eeg-Olofsson K. LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes. Diabet Med. 2016. https://doi.org/10.1111/dme.13007 Published online.

Article  PubMed  Google Scholar 

Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH. Relationship between risk factors and mortality in type 1 diabetic patients in europe: The eurodiab prospective complications study (PCS). Diabetes Care. 2008. https://doi.org/10.2337/dc08-0107 Published online.

Article  PubMed  PubMed Central  Google Scholar 

Costacou T, Evans RW, Orchard TJ. High-density lipoprotein cholesterol in diabetes: Is higher always better? J Clin Lipidol. 2011. https://doi.org/10.1016/j.jacl.2011.06.011 Published online.

Article  PubMed  PubMed Central  Google Scholar 

De Ferranti SD, De Boer IH, Fonseca V, et al. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care. 2014. https://doi.org/10.2337/dc14-1720 Published online.

Article  PubMed  PubMed Central  Google Scholar 

Hamman RF, Bell RA, Dabelea D, et al. The SEARCH for diabetes in youth study: Rationale, findings, and future directions. Diabetes Care. 2014. https://doi.org/10.2337/dc14-0574 Published online.

Article  PubMed  PubMed Central  Google Scholar 

Karamanos B, Porta M, Songini M, et al. Different risk factors of microangiopathy in patients with Type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study. Diabetologia. 2000. https://doi.org/10.1007/s001250050053 Published online.

Article  PubMed  Google Scholar 

United States Department of Health and Human Services. The Health Consequences of smoking–50 years of progress A Report of the Surgeon General. United States Department of Health and Human Services; 2014. Published online.

Google Scholar 

•• Rawshani A, Rawshani A, Franzén S, et al. Range of risk factor levels: control, mortality, and cardiovascular outcomes in type 1 diabetes mellitus. Circulation. 2017. https://doi.org/10.1161/CIRCULATIONAHA.116.025961 Published online. Recent large Swedish National Diabetes Register study, with a follow-up time of 10 years, showing that compared to the control population, people with T1D have twice the risk for MI, even after attaining the corresponding targets for all traditional CVD-related risk factors.

Article  PubMed  PubMed Central  Google Scholar 

American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2015. https://doi.org/10.2337/dc15-S005 Published online.

Article  Google Scholar 

Redondo MJ, Rodriguez LM, Escalante M, O’Brian Smith E, Balasubramanyam A, Haymond MW. Beta cell function and BMI in ethnically diverse children with newly diagnosed autoimmune type 1 diabetes. Pediatr Diabetes. 2012. https://doi.org/10.1111/j.1399-5448.2012.00875.x Published online.

Article  PubMed  Google Scholar 

Dabelea D, D’Agostino RB, Mayer-Davis EJ, et al. Testing the accelerator hypothesis: Body size, β-cell function, and age at onset of type 1 (autoimmune) diabetes. Diabetes Care. 2006. https://doi.org/10.2337/diacare.29.02.06.dc05-1339 Published online.

Article  PubMed  Google Scholar 

• Knerr I, Wolf J, Reinehr T, et al. The “accelerator hypothesis”: relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9,248 German and Austrian children with type 1 diabetes mellitus. Diabetologia. 2005. https://doi.org/10.1007/s00125-005-0033-2 Published online. The "accelaartor hypothesis" postulates that the increased insulin demands caused by obesity lead to faster deterioration of beta cell function in people predisposed to develop T1D. With data from 116 diabetes clinics, this prospective observational study showed that higher BMI was associated with earlier T1D onset in youth and adolescents aged 0–20 years.

Article  PubMed  Google Scholar 

Umpierrez GE. Ketosis-prone type 2 diabetes: time to revise the classification of diabetes. Diabetes Care. 2006. https://doi.org/10.2337/dc06-1870 Published online.

Article  PubMed  Google Scholar 

Østergaard JA, Laugesen E, Leslie RD. Should there be concern about autoimmune diabetes in adults? Current Evidence and Controversies. Curr Diab Rep. 2016. https://doi.org/10.1007/s11892-016-0780-0 Published online.

Article  PubMed  Google Scholar 

Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes. Diabetologia. 2001. https://doi.org/10.1007/s001250100548 Published online.

Article  PubMed  Google Scholar 

Patterson CC, Dahlquist GG, Gyürüs E, et al. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet. 2009. https://doi.org/10.1016/S0140-6736(09)60568-7 Published online.

Article  PubMed  Google Scholar 

Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020. https://doi.org/10.1016/j.jhep.2020.03.039 Published online.

Article  PubMed  Google Scholar 

Bonadonna RC, Cucinotta D, Fedele D, Riccardi G, Tiengo A. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care. 2006. https://doi.org/10.2337/dc06-0942 Published online.

Article  PubMed  Google Scholar 

Teupe B, Bergis K. Epidemiological evidence for “double diabetes.” Lancet. 1991. https://doi.org/10.1016/0140-6736(91)90988-2 Published online.

Article  PubMed  Google Scholar 

Libman IM, Becker DJ. Coexistence of type 1 and type 2 diabetes mellitus: “Double” diabetes? Pediatr Diabetes. 2003. https://doi.org/10.1034/j.1399-5448.2003.00012.x Published online.

Article  PubMed  Google Scholar 

Thorn LM, Forsblom C, Waden J, et al. Effect of parental type 2 diabetes on offspring with type 1 di

留言 (0)

沒有登入
gif